351 related articles for article (PubMed ID: 9920285)
21. In vitro pharmacological characterization of PD 166285, a new nanomolar potent and broadly active protein tyrosine kinase inhibitor.
Panek RL; Lu GH; Klutchko SR; Batley BL; Dahring TK; Hamby JM; Hallak H; Doherty AM; Keiser JA
J Pharmacol Exp Ther; 1997 Dec; 283(3):1433-44. PubMed ID: 9400019
[TBL] [Abstract][Full Text] [Related]
22. Contribution of Src and Ras pathways in FGF-2 induced endothelial cell differentiation.
Klint P; Kanda S; Kloog Y; Claesson-Welsh L
Oncogene; 1999 Jun; 18(22):3354-64. PubMed ID: 10362356
[TBL] [Abstract][Full Text] [Related]
23. Demonstration of functionally different interactions between phospholipase C-gamma and the two types of platelet-derived growth factor receptors.
Eriksson A; Nånberg E; Rönnstrand L; Engström U; Hellman U; Rupp E; Carpenter G; Heldin CH; Claesson-Welsh L
J Biol Chem; 1995 Mar; 270(13):7773-81. PubMed ID: 7535778
[TBL] [Abstract][Full Text] [Related]
24. Signal transduction proteins that associate with the platelet-derived growth factor (PDGF) receptor mediate the PDGF-induced release of glucose-6-phosphate dehydrogenase from permeabilized cells.
Tian WN; Pignatare JN; Stanton RC
J Biol Chem; 1994 May; 269(20):14798-805. PubMed ID: 8182086
[TBL] [Abstract][Full Text] [Related]
25. Downregulation of platelet-derived growth factor receptor-beta in Shp-2 mutant fibroblast cell lines.
Lu X; Qu CK; Shi ZQ; Feng GS
Oncogene; 1998 Jul; 17(4):441-8. PubMed ID: 9696037
[TBL] [Abstract][Full Text] [Related]
26. Tyrphostins. 5. Potent inhibitors of platelet-derived growth factor receptor tyrosine kinase: structure-activity relationships in quinoxalines, quinolines, and indole tyrphostins.
Gazit A; App H; McMahon G; Chen J; Levitzki A; Bohmer FD
J Med Chem; 1996 May; 39(11):2170-7. PubMed ID: 8667360
[TBL] [Abstract][Full Text] [Related]
27. Mutation of a Src phosphorylation site in the PDGF beta-receptor leads to increased PDGF-stimulated chemotaxis but decreased mitogenesis.
Hansen K; Johnell M; Siegbahn A; Rorsman C; Engström U; Wernstedt C; Heldin CH; Rönnstrand L
EMBO J; 1996 Oct; 15(19):5299-313. PubMed ID: 8895575
[TBL] [Abstract][Full Text] [Related]
28. Platelet-derived growth factor-BB-induced human smooth muscle cell proliferation depends on basic FGF release and FGFR-1 activation.
Millette E; Rauch BH; Defawe O; Kenagy RD; Daum G; Clowes AW
Circ Res; 2005 Feb; 96(2):172-9. PubMed ID: 15625285
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of the novel selective platelet-derived growth factor receptor antagonist CT52923 on cellular proliferation, migration, and suppression of neointima following vascular injury.
Yu JC; Lokker NA; Hollenbach S; Apatira M; Li J; Betz A; Sedlock D; Oda S; Nomoto Y; Matsuno K; Ide S; Tsukuda E; Giese NA
J Pharmacol Exp Ther; 2001 Sep; 298(3):1172-8. PubMed ID: 11504817
[TBL] [Abstract][Full Text] [Related]
30. v-mos suppresses platelet-derived growth factor (PDGF) type-beta receptor autophosphorylation and inhibits PDGF-BB-mediated signal transduction.
Faller DV; Mundschau LJ; Forman LW; Quiñones MA
J Biol Chem; 1994 Feb; 269(7):5022-9. PubMed ID: 8106477
[TBL] [Abstract][Full Text] [Related]
31. Biological function of PDGF-induced PI-3 kinase activity: its role in alpha PDGF receptor-mediated mitogenic signaling.
Yu JC; Gutkind JS; Mahadevan D; Li W; Meyers KA; Pierce JH; Heidaran MA
J Cell Biol; 1994 Oct; 127(2):479-87. PubMed ID: 7929590
[TBL] [Abstract][Full Text] [Related]
32. Effect of herbimycin A on tyrosine kinase receptors and platelet derived growth factor (PDGF)-induced signal transduction.
Murakami Y; Fukazawa H; Mizuno S; Uehara Y
Biol Pharm Bull; 1998 Oct; 21(10):1030-5. PubMed ID: 9821805
[TBL] [Abstract][Full Text] [Related]
33. Dimerization drives PDGF receptor endocytosis through a C-terminal hydrophobic motif shared by EGF receptor.
Pahara J; Shi H; Chen X; Wang Z
Exp Cell Res; 2010 Aug; 316(14):2237-50. PubMed ID: 20580638
[TBL] [Abstract][Full Text] [Related]
34. Tyrosine kinase inhibitors. 6. Structure-activity relationships among N- and 3-substituted 2,2'-diselenobis(1H-indoles) for inhibition of protein tyrosine kinases and comparative in vitro and in vivo studies against selected sulfur congeners.
Showalter HD; Sercel AD; Leja BM; Wolfangel CD; Ambroso LA; Elliott WL; Fry DW; Kraker AJ; Howard CT; Lu GH; Moore CW; Nelson JM; Roberts BJ; Vincent PW; Denny WA; Thompson AM
J Med Chem; 1997 Feb; 40(4):413-26. PubMed ID: 9046331
[TBL] [Abstract][Full Text] [Related]
35. Insight into the role of low molecular weight phosphotyrosine phosphatase (LMW-PTP) on platelet-derived growth factor receptor (PDGF-r) signaling. LMW-PTP controls PDGF-r kinase activity through TYR-857 dephosphorylation.
Chiarugi P; Cirri P; Taddei ML; Giannoni E; Fiaschi T; Buricchi F; Camici G; Raugei G; Ramponi G
J Biol Chem; 2002 Oct; 277(40):37331-8. PubMed ID: 12149261
[TBL] [Abstract][Full Text] [Related]
36. A rapid bioassay for platelet-derived growth factor beta-receptor tyrosine kinase function.
Graminski GF; Lerner MR
Biotechnology (N Y); 1994 Oct; 12(10):1008-11. PubMed ID: 7765404
[TBL] [Abstract][Full Text] [Related]
37. Regulation of chemotaxis by the platelet-derived growth factor receptor-beta.
Kundra V; Escobedo JA; Kazlauskas A; Kim HK; Rhee SG; Williams LT; Zetter BR
Nature; 1994 Feb; 367(6462):474-6. PubMed ID: 8107807
[TBL] [Abstract][Full Text] [Related]
38. Sunitinib induces PTEN expression and inhibits PDGFR signaling and migration of medulloblastoma cells.
Abouantoun TJ; Castellino RC; MacDonald TJ
J Neurooncol; 2011 Jan; 101(2):215-26. PubMed ID: 20524040
[TBL] [Abstract][Full Text] [Related]
39. Negative feedback regulation of human platelets via autocrine activation of the platelet-derived growth factor alpha-receptor.
Vassbotn FS; Havnen OK; Heldin CH; Holmsen H
J Biol Chem; 1994 May; 269(19):13874-9. PubMed ID: 8188664
[TBL] [Abstract][Full Text] [Related]
40. Antiangiogenic and antitumor activity of a selective PDGFR tyrosine kinase inhibitor, CP-673,451.
Roberts WG; Whalen PM; Soderstrom E; Moraski G; Lyssikatos JP; Wang HF; Cooper B; Baker DA; Savage D; Dalvie D; Atherton JA; Ralston S; Szewc R; Kath JC; Lin J; Soderstrom C; Tkalcevic G; Cohen BD; Pollack V; Barth W; Hungerford W; Ung E
Cancer Res; 2005 Feb; 65(3):957-66. PubMed ID: 15705896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]